Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

sasanalyst Jan. 11 at 10:21 PM

$BCTX Top 11 readouts to watch out in 2026 per the Nature Journal.

0 · Reply

Rohtan Jan. 10 at 12:29 AM

$BCTX will the dust ever end on this? Will they do another RS here? Not even a single long term invois happy with this company I guess.

0 · Reply

Fvalstounge Jan. 9 at 10:46 PM

$BCTX I just don't see any movement or interest here until after they close the offering and extend the runway well into Q3 at the current burn rate or better. Anything less just leaves too much uncertainty. One can bet their money on early intervention from the DSMB, but that's still a lotto ticket play. If it comes, I still say the March meeting is most likely. After that, they may as well wait for the 144 events.

4 · Reply

Rohtan Jan. 9 at 7:57 PM

$BCTX no pulse

0 · Reply

JediGreen Jan. 9 at 4:59 PM

$BCTX If I bank out on this stock. I’d really like to buy a car wash. Ready to leave the foundry 🌋 9 to 5 . 110K in this.

0 · Reply

EscapePlan Jan. 9 at 4:10 PM

$BCTX $13 per day for my little 800 share holding.... THank you shorts

0 · Reply

EscapePlan Jan. 9 at 4:00 PM

$BCTX I'm happy getting my 122.014% on loaning out my shares to the shorts

0 · Reply

2maligators Jan. 5 at 6:45 PM

$BCTX up or down can we just have some consistency here🥴

0 · Reply

Sb123321 Jan. 5 at 5:24 PM

$BCTX why is there still a bid for the Feb '26 warrants?

0 · Reply

Emerald_Stock_Alerts_ Jan. 5 at 2:40 PM

$BCTX ON VERY HIGH ALERT 🚨

0 · Reply

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

Dec 10, 2025, 7:30 AM EST - 4 weeks ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Dec 9, 2025, 7:30 AM EST - 4 weeks ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

Dec 2, 2025, 7:30 AM EST - 5 weeks ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 6 weeks ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Nov 20, 2025, 7:30 AM EST - 7 weeks ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 18, 2025, 7:30 AM EST - 7 weeks ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 7, 2025, 7:30 AM EST - 2 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 4, 2025, 7:30 AM EST - 2 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Oct 22, 2025, 7:30 AM EDT - 2 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Oct 21, 2025, 7:50 AM EDT - 2 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:30 AM EDT - 2 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 20, 2025, 7:30 AM EDT - 2 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 3 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 3, 2025, 7:30 AM EDT - 3 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Aug 26, 2025, 7:30 AM EDT - 4 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 4 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 5 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 5 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 5 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 5 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 5 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 6 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 6 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 6 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 6 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 6 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 6 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 6 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 6 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 6 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jun 24, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 4, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Jun 2, 2025, 7:30 AM EDT - 7 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

May 27, 2025, 7:30 AM EDT - 8 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

May 23, 2025, 7:30 AM EDT - 8 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

May 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell CEO Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 9 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

Apr 28, 2025, 4:05 PM EDT - 9 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Apr 28, 2025, 7:30 AM EDT - 9 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Apr 24, 2025, 8:00 PM EDT - 9 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Apr 24, 2025, 10:11 AM EDT - 9 months ago

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

Apr 24, 2025, 7:30 AM EDT - 9 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Apr 23, 2025, 7:30 AM EDT - 9 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 22, 2025, 7:30 AM EDT - 9 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

Apr 16, 2025, 7:30 AM EDT - 9 months ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

Mar 26, 2025, 8:00 AM EDT - 10 months ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

Mar 20, 2025, 8:00 AM EDT - 10 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer

Feb 5, 2025, 6:15 PM EST - 1 year ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Feb 5, 2025, 4:05 PM EST - 1 year ago

BriaCell Therapeutics Announces Closing of Public Offering

sasanalyst Jan. 11 at 10:21 PM

$BCTX Top 11 readouts to watch out in 2026 per the Nature Journal.

0 · Reply

Rohtan Jan. 10 at 12:29 AM

$BCTX will the dust ever end on this? Will they do another RS here? Not even a single long term invois happy with this company I guess.

0 · Reply

Fvalstounge Jan. 9 at 10:46 PM

4 · Reply

Rohtan Jan. 9 at 7:57 PM

$BCTX no pulse

0 · Reply

JediGreen Jan. 9 at 4:59 PM

$BCTX If I bank out on this stock. I’d really like to buy a car wash. Ready to leave the foundry 🌋 9 to 5 . 110K in this.

0 · Reply

EscapePlan Jan. 9 at 4:10 PM

$BCTX $13 per day for my little 800 share holding.... THank you shorts

0 · Reply

EscapePlan Jan. 9 at 4:00 PM

$BCTX I'm happy getting my 122.014% on loaning out my shares to the shorts

0 · Reply

2maligators Jan. 5 at 6:45 PM

$BCTX up or down can we just have some consistency here🥴

0 · Reply

Sb123321 Jan. 5 at 5:24 PM

$BCTX why is there still a bid for the Feb '26 warrants?

0 · Reply

Emerald_Stock_Alerts_ Jan. 5 at 2:40 PM

$BCTX ON VERY HIGH ALERT 🚨

0 · Reply

ManuTa Jan. 1 at 7:31 PM

$BCTX planning to start adding more below $5

0 · Reply

JediGreen Dec. 31 at 11:23 PM

$BCTX The movie twister 🌪️. When Bill picks up dirt from ground and drops it in the wind and says going Green. It’s the extreme.

0 · Reply

WallStreetBuyDip Dec. 30 at 3:11 AM

Comparing trending tickers $BCTX vs $RARE: BCTX has dropped to $7.05, showing an 8.91% decrease, with trading volume reaching 120.7K, slightly above its average of 104.8K. On the other hand, RARE has taken a sharper hit, declining 42.32% to $19.72, on a significantly higher volume of 21.7M shares, which is well over 15 times its usual volume of 1.4M. While both stocks are experiencing higher than average trading activity, RARE's dramatic price drop and massive volume surge indicate a more volatile market response compared to BCTX.

0 · Reply

WallStreetBuyDip Dec. 30 at 2:56 AM

Comparing trending tickers $PPLT vs $BCTX: PPLT dropped significantly to $192.78, a 12.43% decrease, on a high trading volume of 3.2M shares, which is well above its average (about 8 times the norm). BCTX also saw a decline, down 8.91% to $7.05, with trading volume reaching 120.7K shares, slightly above its usual volume. While both stocks experienced notable drops, PPLT's trading activity was particularly high compared to its average, suggesting a more dramatic shift in investor sentiment.

0 · Reply

MoeMaze Dec. 30 at 12:27 AM

$BCTX $BCTX Plenty of trials, plenty of promises — somehow the stock was the only casualty. #bctx #briacell @BriaCell #stocks #cancer #nasdaq

0 · Reply

MoeMaze Dec. 30 at 12:26 AM

$BCTX $BCTX Less than 4 months I said it , and here.. it’s happening again ! New public offering, which made the #stock go down by 30%Mr Willy “ William” and then what ! … Do u enjoy “ #SUCKING #MONEY “ that much !plz enough and try to find something other than money! 😉

0 · Reply

MoeMaze Dec. 30 at 12:17 AM

$BCTX #Public offering ➡️ Reverse split,Public offering ➡️ Reverse split,Public offering 🔂.. till when R we gonna stay in this vicious Circle? and all under the excuse of “ New #Cancer treatment “ , I think u R the real Cancer, and WE need to find a treatment! $BCTX @BriaCell #Stocks

1 · Reply

JohnTrack Dec. 29 at 11:44 PM

$BCTX eyes peeled, nothing forced...

0 · Reply

JohnTrack Dec. 29 at 9:11 PM

$BCTX financial results released https://www.rapidticker.com/news/bctx-sec-filing-0c70d2

0 · Reply

MarkeTimer Dec. 29 at 8:34 PM

$BCTX 25mm shares at $3?

2 · Reply

JediGreen Dec. 29 at 6:39 PM

$BCTX You guys want to see how Bullish I am. This is how much money I’m paying on Taxes just to keep my position in this stock.

3 · Reply

GoldenChic Dec. 29 at 4:35 PM

$BCTX keep feeding the daytrader...

1 · Reply

Market Cap	13.66M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	47,300
Avg Vol	61,648
Day's Range	N/A - N/A
Shares Out	1.88M
Stochastic %K	29%
Beta	1.38
Analysts	Strong Buy
Price Target	$40.00